Awareness of the contributions of impaired insulin/IGF-1 signaling in alcohol-related brain diseases led to the concept that the deleterious effects of ethanol could be minimized or prevented by therapeutic targeting with insulin sensitizer agents. Here, INS is linked to brain disorder.